Literature DB >> 22676569

HIV/AIDS and drug use in China--interactions, impacts, and issues.

Min Zhao1, Walter Ling.   

Abstract

The interrelationships of HIV/AIDS and drug use and misuse result in complex problems that have been addressed by a variety of sociolegal approaches that often are in contrast to evidence-based medical practices proven effective in reducing associated harms. Like other countries struggling to reduce the incidence and consequences of addiction and HIV/AIDS, China is working to improve systems of care and to revise policies toward drug use and misuse and HIV/AIDS. Greater interaction with researchers and clinicians from around the world can foster increased awareness of effective practices and help implement effective strategies to deal with the problems of HIV/AIDS, and addiction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22676569      PMCID: PMC4151620          DOI: 10.3109/10826084.2012.663284

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  45 in total

1.  Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet.

Authors:  L Amass; J B Kamien; S K Mikulich
Journal:  Drug Alcohol Depend       Date:  2000-02-01       Impact factor: 4.492

2.  Office-based treatment for opioid dependence: reaching new patient populations.

Authors:  D A Fiellin; R A Rosenheck; T R Kosten
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

3.  Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.

Authors:  Julia H Arnsten; Penelope A Demas; Richard W Grant; Marc N Gourevitch; Homayoon Farzadegan; Andrea A Howard; Ellie E Schoenbaum
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

4.  China and HIV - a window of opportunity.

Authors:  Bates Gill; Susan Okie
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

5.  Effectiveness of first eight methadone maintenance treatment clinics in China.

Authors:  Lin Pang; Yang Hao; Guodong Mi; Changhe Wang; Wei Luo; Keming Rou; Jianhua Li; Zunyou Wu
Journal:  AIDS       Date:  2007-12       Impact factor: 4.177

6.  Reawakening the dragon: changing patterns of opiate use in Asia, with particular emphasis on China's Yunnan province.

Authors:  C B McCoy; H V McCoy; S Lai; Z Yu; X Wang; J Meng
Journal:  Subst Use Misuse       Date:  2001-01       Impact factor: 2.164

7.  Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy.

Authors:  Michael M Copenhaver; Blair T Johnson; I-Ching Lee; Jennifer J Harman; Michael P Carey
Journal:  J Subst Abuse Treat       Date:  2006-07-13

8.  Linkage with methadone treatment upon release from incarceration: a promising opportunity.

Authors:  Josiah D Rich; Michelle McKenzie; David C Shield; Francis A Wolf; R Garrett Key; Michael Poshkus; Jennifer Clarke
Journal:  J Addict Dis       Date:  2005

9.  The Chinese free antiretroviral treatment program: challenges and responses.

Authors:  Fujie Zhang; Jessica E Haberer; Yu Wang; Yan Zhao; Ye Ma; Decai Zhao; Lan Yu; Eric P Goosby
Journal:  AIDS       Date:  2007-12       Impact factor: 4.177

10.  HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.

Authors:  J Allen McCutchan; Julia W Wu; Kevin Robertson; Susan L Koletar; Ronald J Ellis; Susan Cohn; Michael Taylor; Steven Woods; Robert Heaton; Judith Currier; Paige L Williams
Journal:  AIDS       Date:  2007-05-31       Impact factor: 4.177

View more
  2 in total

1.  Positive percentages of urine morphine tests among methadone maintenance treatment clients with HIV/AIDS: a 12-month follow-up study in Guangdong Province, China.

Authors:  Xiaofeng Luo; Xiao Gong; Peizhen Zhao; Xia Zou; Wen Chen; Li Ling
Journal:  BMJ Open       Date:  2017-04-27       Impact factor: 2.692

2.  Concurrent Heroin Use and Correlates among Methadone Maintenance Treatment Clients: A 12-Month Follow-up Study in Guangdong Province, China.

Authors:  Xiaofeng Luo; Peizhen Zhao; Xiao Gong; Lei Zhang; Weiming Tang; Xia Zou; Wen Chen; Li Ling
Journal:  Int J Environ Res Public Health       Date:  2016-03-09       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.